SeNostic GmbH

SeNostic GmbH is a diagnostics company that develops its proprietary SeedCycler® technology platform for the precise and accurate early differential diagnosis of multiple neurodegenerative disorders, including Alzheimer’s disease, dementia with Lewy bodies or Parkinson’s disease. The SeedCycler® technology provides a unique way to amplify and characterize disease-specific protein aggregates (Seed-biomarkers) present in tissues and body fluids. These are characteristic for pathological disease processes, and increase over disease progression. The potential for highly accurate in vitro diagnostics, which especially avoids false-positive results, has a world-wide market potential for today’s clinical diagnostics, for future preclinical diagnostics and for the stratification and follow-up of pharmaceutical clinical trials.